ScholarIQanswers from OpenAlex

Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity

PaperCitations, authors & open-access status

Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity have?

ScholarIQcitation count

Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity has 34 citations in the OpenAlex counts ScholarIQ stores.

When was Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity published?

ScholarIQyear

Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity has 2014 year in the ScholarIQ index.

What is the open-access status of Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity?

ScholarIQoa status

Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity has green oa status in the ScholarIQ index.

What is the DOI of Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity?

ScholarIQdoi

The DOI for Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity is on the source record.

What is the PMID of Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity?

ScholarIQpmid

The PMID for Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity is on the source record.

What is the OpenAlex record for Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity?

ScholarIQopenalex

The OpenAlex for Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial